Karyopharm Therapeutics | Ticaret Alacaklılar





Ticaret Alacaklılar Değişiklik Tarih
AbbVie USD 32.25B 1.2B 2025-06
Abbott USD 4.12B 183M 2025-09
Amgen USD 20.89B 1.25B 2025-12
AstraZeneca USD 25.03B 1.04B 2025-09
BioCryst Pharmaceuticals USD 5.57M 3.02M 2025-09
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Eli Lilly USD 4.26B 186.5M 2025-09
Enanta Pharmaceuticals USD 1.95M 1.6M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Incyte USD 1.63B 1.46B 2025-12
J&J USD 9.62B 161M 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
MacroGenics USD 5.94M 1.28M 2025-09
Merck USD 4.15B 102M 2025-09
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Novartis USD 4.56B 49M 2025-09
Novartis USD 4.56B 49M 2025-09
Pfizer USD 5.02B 142M 2025-09
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Takeda JPY 467.59B 28.61B 2025-12
Tectonic Therapeutic USD 1.48M 1.32M 2025-09
TG Therapeutics USD 61.64M 72.38M 2025-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Xencor USD 9.08M 9.45M 2025-09


Karyopharm Therapeutics Ticaret Alacaklılar - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Feb 2026.